Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib vs Capecitabine in Premenopausal Metastatic Breast Cancer (Young-PEARL)
NCT02592746Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jun 2016
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02592746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02592746.